PharmAla Biotech
$0.09
23
+$0.03+47.9% 今天
统计数据
当日最高
0.07
当日最低
0.07
52周最高
0.35
52周最低
0.03
成交量
1,428
平均成交量
11,541
市值
-
市盈率
-
股息收益率
-
股息
-
人们还关注
此列表基于关注MDXXF的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
Compass Pathways
CMPS
市值511.54M
Mind Medicine
MNMD
市值493.47M
GH Research
GHRS
市值546.3M
ATAI Life Sciences N.V.
ATAI
市值218.14M
Cybin
CYBN
市值194.47M
Revive Therapeutics
RVVTF
市值3.99M
关于
Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.
Show more...
首席执行官
Mr. Nicholas Kadysh
国家
CA
ISIN
CA71719L1067